LISINOPRIL
- Product NDC
- 51655-335
- 11-digit product format
- 516550335
- Labeler code
- 51655
- Product ID
- 51655-335_48eb0bba-4c41-73b4-e063-6294a90a7a83
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Northwind Health Company, LLC
- Application
- ANDA076164
- Marketing category
- ANDA
- Marketing start
- 2020-05-21
- Substance
- LISINOPRIL
- Active strength
- 40 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- LISINOPRIL
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LISINOPRIL | 40 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | E7199S1YWR |
| Rxcui | 197884 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51655-335-26 | LISINOPRIL | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51655-335 | LISINOPRIL TABLET [NORTHWIND PHARMACEUTICALS, LLC] | 4 | Current NDC, Legacy NDC, 1 package rows | 20241225_ab2f8ab5-3c87-484a-e053-2995a90a42bb.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51655-335-26 | 51655033526 | 90 TABLET in 1 BOTTLE, PLASTIC (51655-335-26) | 90 tablet | 2020-05-21 | 0000-00-00 | No | No | Current |